SUPRESSION OF BIOFILMS OF OPPORTUNISTIC BACTERIA IN URINARY CATHETERS
- Authors: Rybalchenko O.V.1, Erman M.V.1, Orlova O.G.1, Pervunina T.M.1, Kapustina V.V.1, Pariyskaya E.N.1
-
Affiliations:
- St. Petersburg State University
- Issue: Vol 94, No 3 (2017)
- Pages: 3-11
- Section: ORIGINAL RESEARCHES
- URL: https://microbiol.crie.ru/jour/article/view/154
- DOI: https://doi.org/10.36233/0372-9311-2017-3-3-11
- ID: 154
Cite item
Full Text
Abstract
About the authors
O. V. Rybalchenko
St. Petersburg State University
Author for correspondence.
Russian Federation
M. V. Erman
St. Petersburg State UniversityRussian Federation
O. G. Orlova
St. Petersburg State UniversityRussian Federation
T. M. Pervunina
St. Petersburg State UniversityRussian Federation
V. V. Kapustina
St. Petersburg State UniversityRussian Federation
E. N. Pariyskaya
St. Petersburg State UniversityRussian Federation
References
- Вдовиченко В.П., Вронская Г.М., КоршакТ.А., КазакевичД.В., Соколов Н.К., Щеврук А.Н.; АЛ., Акуленец Е.В. Нитрофураны в фармакотерапии инфекций мочевыводящих путей. - Медицинские новости. 2012, 3: 38-41.
- Гресь АА, Вощула В.И., Рыбина И.Л. и др. Мочекаменная болезнь: опыт применения и эффективность Канефрона Н. Медицинские новости. 2004, 8: 89-93.
- Рыбалъченко О.В. Электронно-микроскопическое исследование межклеточных взаимодействии микроорганизмов при антагонистическом характере взаимоотношении. Микробиология. 2006, 75 (4): 550-555.
- РыбальченкоО.В., Бондаренко В.М. Биопленкообразование как форма существования индигенных и транзиторных представителей микробиоты кишечника. Вестник СПбГУ. 2013,11(1): 179-186.
- Яковлев С.В. и др. Клиническая и бактериологическая эффективность препарата «Фурамаг» у пациентов с острым циститом. Инфекции и антимикробная терапия. 2005, 7(4): 1-6.
- Crabtree J.H., Burchette R.J., Siddiqi R.A. et al. Efficacy of silver-ion implanted catheters in reducing peritoneal dialysis-related infections. Perit. Dial. Int. 2003, 23: 368-374.
- Costerton J. W., Stewart P. S., Greenberg E. P. Bacterial biofilms: a common cause of persistent infections. Science. 1999, 284: 1318-1322.
- Donlan R.M., Costerton J.W. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 2002, 15: 167-193.
- Dudeck M.A., Weiner L.M., Allen-Bridson K. et al. National Healthcare Safety Network (NHSN) report, data summary for 2012, device-associated module. Am. J. Infect. Control. 2013,41:1148-1166.
- Fisher L.E., Hook A.L., Ashraf W. et al. Biomaterial modification of urinary catheters with antimicrobials to givelong-term broad spectrum antibiofilm activity. J. Controlled Release. 2015,202: 57-64.
- Holmes P.F., Currie E.P., Thies J.C. et al. Surfacemodified nanoparticles as a new, versatile, and mechanically robust nonadhesive coating: suppression of protein adsorption and bacterial adhesion. J. Biomed. Mater. Res. 2009, 91A: 824-833.
- Katzung B.G. Basic&Clinical Pharmacology. McGraw-Hill. 2009, 9: 820-826.
- Kurt G. N. Efficacy and safety of the phytotherapeutic drug Canephron® N in prevention and treatment of urogenital and gestational disease: review of clinical experience in Eastern Europe and Central Asia. Res. Rep. Urol. 2013, 5: 39-46.
- Stickler D.J., Morgan S.D. Observations on the development of the crystalline bacterial biofilms that encrust and block Foley catheters. J. Hosp. Infect. 2008, 69: 350-360.
- Tenke R, Kovacs B. et al. European and Asian guidelines on management and prevention of catheter-associated urinary tract infections. Int. J. Antimicrob. Agents. 2008 Feb, 31 (1): S68-78.
- Toole G.A. To build a biofilm. J. Bacteriol. 2003, 185: 2687-2689.
Supplementary files


